Ultrasound Parameters for the Outcome Prediction of External Cephalic Version for Fetuses with Breech Presentation

NCT ID: NCT06593795

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

120 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-10-31

Study Completion Date

2026-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate possible predictors for the successful od external cephalic version (ECV), a procedure that is indicated in your case due to breech presentation of your baby and your desire to avoid cesarean section. Before the procedure, a detailed ultrasound scan will be performed to measure several parameters. After the procedure we will collect data about the duration, outcome and eventual complications of ECV.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pregnant women with a diagnosis of fetal breech presentation, desirous of an attempt of ECV after counseling and written consent and hospitalized for the procedure will be consecutively enrolled. The following anonymous data will be recorded:

* Demographic and anthropometric data (i.e., age (y), ethnicity, height (m), weight (kg), BMI);
* Parity
* Gestational Age (weeks + days)

Before ECV attempt, the following evaluations will be performed:

* Vaginal examination to evaluate the cervical dilatation and the level of presenting part (floating or not floating)
* Fetal transvaginal ultrasound reporting:

* biometry (BPD, HC, AC, FL, EFW);
* Occiput position (right, left);
* Back position (anterior, posterior, right, left);
* Breech variant (footling, frank, complete);
* Fetal leg posture (extended, flexed)
* Placental localization;
* Amniotic Fluid Index (AFI);
* Fore-bag of amniotic fluid;
* Eventual presence of nuchal cords;
* Fetal head ballottement (yes, no);
* Occiput-spine angle (see Figure 1)

Then, all the participants will undergo a transabdominal ultrasound-guided ECV in a semi-sitting position by the same expert operator (B.C.). After the procedure, the following data will be collected:

* Success (yes, no)
* Duration of the procedure (min);
* Direction of fetal flip in case of success (frontside flip, backside flip)
* Pain perception in Numerical Rating Scale (NRS) (1-10);
* Reason for terminating the procedure (success, failure, pain, uterine contractions, non-reassuring fetal conditions)

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breech Fetal Presentation Breech Presentation of Fetus with Successful Version Vaginal Delivery Cesarean Section

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group ECV

Pregnant women with a fetus in breech presentation at term of pregnancy undergoing an external cephalic version (ECV) maneuver. This procedure is aimed to induce fetal cephalic position allowing vaginal delivery instead of cesarean section

ultrasound

Intervention Type PROCEDURE

before ECV procedure, an ultrasound will be performed to evaluate

* fetal biometry (BPD, HC, AC, FL, EFW);
* Occiput position (right, left);
* Back position (anterior, posterior, right, left);
* Breech variant (footling, frank, complete);
* Fetal leg posture (extended, flexed)
* Placental localization;
* Amniotic Fluid Index (AFI);
* Fore-bag of amniotic fluid;
* Eventual presence of nuchal cords;
* Fetal head ballottement (yes, no);
* Occiput-spine angle These parameters will be compared to find predictive factors for successful ECV

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ultrasound

before ECV procedure, an ultrasound will be performed to evaluate

* fetal biometry (BPD, HC, AC, FL, EFW);
* Occiput position (right, left);
* Back position (anterior, posterior, right, left);
* Breech variant (footling, frank, complete);
* Fetal leg posture (extended, flexed)
* Placental localization;
* Amniotic Fluid Index (AFI);
* Fore-bag of amniotic fluid;
* Eventual presence of nuchal cords;
* Fetal head ballottement (yes, no);
* Occiput-spine angle These parameters will be compared to find predictive factors for successful ECV

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥18 y.o.;
* Pregnant women with a diagnosis of fetal breech presentation eligible and desirous for ECV;
* Singleton;
* At term (≥ 37 weeks);
* Breech presentation;
* No previous uterine scars or other indications for elective C-section;
* Signed written informed consent to study participation.

Exclusion Criteria

* Age \<18 y.o.;
* Preterm gestational age;
* Multiple pregnancies;
* Indications for elective cesarean section;
* Incomplete obstetrical data;
* Refusal to provide informed consent.
* Desire to an elective C-Section
* Controindications for ECV or vaginal delivery (placental abruption, placenta previa, uterine malformations)
* Reduction of amniotic fluid (AFI \<4 cm)
* Uterine contractions
* Vaginal bleeding
* Premature rupture of membranes
* Nonreassuring fetal heart rate patterns before the procedure.
Minimum Eligible Age

18 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Carducci Brigida

MD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

silvio tartaglia, MD

Role: STUDY_DIRECTOR

Fondazione Policlinico Universitario A. Gemelli, IRCCS

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Silvio Tartaglia, MD

Role: CONTACT

(555) 555-1234

Sascia Moresi, MD

Role: CONTACT

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

6366

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

R. I. S. POS. T. A
NCT01991665 UNKNOWN NA